YM-175 induces apoptosis of human native monocyte-lineage cells via inhibition of prenylation.
Article Details
- CitationCopy to clipboard
Miwa A, Takezako N, Hayakawa H, Hayakawa M, Tominaga S, Yanagisawa K
YM-175 induces apoptosis of human native monocyte-lineage cells via inhibition of prenylation.
Am J Hematol. 2012 Dec;87(12):1084-8. doi: 10.1002/ajh.23328. Epub 2012 Oct 9.
- PubMed ID
- 23044853 [ View in PubMed]
- Abstract
Nitrogen-containing bisphosphonates (NCBPs) have been widely used as standard supportive therapy to reduce skeletal-related events (SREs) in myeloma patients through suppression of osteoclast activity. In various prospective randomized trials that were performed following preliminary reports concerning efficacy, NCBPs have shown a significant beneficial effect on myeloma bone disease through both suppression of bone resorption and direct antimyeloma activity. Thus, NCBPs have an influence on many types of human cells. In this study, we examined the effect of an NCBP (YM-175) on an apoptosis of a monocytic cell line and of human native monocytes/macrophages and dendritic cells (DCs). We confirmed that monocytes, monocyte-derived macrophages, DCs, and a monoblastic cell line (THP-1) showed dose-dependent and time-dependent apoptosis related to the activation of caspases after exposure to YM-175 at concentrations below that at which the apoptosis of myeloma cell lines was induced. Such apoptosis of monocytic cells was suppressed by the addition of farnesol or geranylgeraniol. These findings suggest that the inhibition of monocyte-lineage cells or DCs by NCBPs might interfere with phagocytic activity or pathogen-presenting activity.
DrugBank Data that Cites this Article
- Drugs
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Incadronic acid Caspase-3 Protein Humans UnknownActivatorDetails Incadronic acid Caspase-4 Protein Humans UnknownActivatorDetails Incadronic acid Caspase-7 Protein Humans UnknownActivatorDetails Incadronic acid Farnesyl pyrophosphate synthase Protein Humans UnknownInhibitorDetails